{"id":241057,"date":"2026-07-17T00:34:58","date_gmt":"2026-07-17T05:34:58","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/new-multiple-sclerosis-criteria-could-reveal-disease-before-symptoms-appear"},"modified":"2026-07-17T00:34:58","modified_gmt":"2026-07-17T05:34:58","slug":"new-multiple-sclerosis-criteria-could-reveal-disease-before-symptoms-appear","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/new-multiple-sclerosis-criteria-could-reveal-disease-before-symptoms-appear","title":{"rendered":"New multiple sclerosis criteria could reveal disease before symptoms appear"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-multiple-sclerosis-criteria-could-reveal-disease-before-symptoms-appear2.jpg\"><\/a><\/p>\n<p>The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most significant overhaul in a decade in 2024. The internationally recognized framework is used to diagnose MS by combining clinical, imaging and laboratory findings. Dr. Jiwon Oh, director of the BARLO MS Centre at St. Michael\u2019s Hospital, was among the experts who helped write them.<\/p>\n<p>Now, in a commentary <a href=\"https:\/\/www.nature.com\/articles\/s41591-026-04490-8\" target=\"_blank\">published<\/a> in <i>Nature Medicine<\/i>, Oh has brought together nearly 30 of the world\u2019s leading MS clinicians to critically evaluate what those changes mean and where the field must go next to improve health outcomes for people with MS. Many of its co-authors also helped develop the revised criteria in 2024.<\/p>\n<p>\u201cThis commentary looks critically at the new criteria and explains why these changes matter, what challenges may arise as they\u2019re used, and what can be done to address them,\u201d explains Oh. \u201cIt also takes a broader look at where the field needs to go next.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most significant overhaul in a decade in 2024. The internationally recognized framework is used to diagnose MS by combining clinical, imaging and laboratory findings. Dr. Jiwon Oh, director of the BARLO MS Centre at St. Michael\u2019s Hospital, was among the experts [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,47],"tags":[],"class_list":["post-241057","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=241057"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241057\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=241057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=241057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=241057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}